RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,090,796 | -14.6% | 125,800 | -3.9% | 0.00% | – |
| Q2 2023 | $2,447,830 | -30.8% | 130,900 | -32.1% | 0.00% | -100.0% |
| Q1 2023 | $3,535,421 | -0.8% | 192,666 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $3,565,584 | -19.3% | 180,080 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $4,419,000 | +284.3% | 183,645 | +191.5% | 0.00% | – |
| Q2 2022 | $1,150,000 | -42.4% | 63,000 | -30.6% | 0.00% | – |
| Q1 2022 | $1,997,000 | -58.0% | 90,808 | -29.9% | 0.00% | – |
| Q4 2021 | $4,756,000 | +194.5% | 129,518 | +149.1% | 0.00% | – |
| Q3 2021 | $1,615,000 | -83.2% | 52,000 | -82.8% | 0.00% | -100.0% |
| Q2 2021 | $9,597,000 | +104.5% | 301,893 | +42.8% | 0.00% | – |
| Q1 2021 | $4,693,000 | +46.0% | 211,404 | +29.9% | 0.00% | – |
| Q4 2020 | $3,214,000 | – | 162,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |